Abstract
The treatment of skin cancers represents a growing share of healthcare expenditures. However, little is known about how variations in payment rates relate to the use of different skin cancer procedures. This study describes recent trends in payment rates, use rates, and overall expenditures for skin cancer procedures in the Medicare Part B population. In this ecological study, we used the Medicare Physician Supplier and Other Provider Public Use File (POSPUF) to analyze trends in Medicare payment rates, use rates, and overall Medicare expenditures for skin cancer procedures from 2012 to 2017. We adjusted reimbursement rates for inflation by converting payment amounts into units of 2017 dollars. From 2012 to 2017, overall inflation-adjusted Medicare expenditure on skin cancer procedures increased 9%. Over this time period, inflation-adjusted Medicare reimbursement rates declined for each procedure class, with the exception of shave excision. Concurrently, the use rate of Mohs micrographic surgery increased 21%, while the use rate for all other skin cancer procedure classes declined. In summary, the results of this study suggest that increased use of Mohs has displaced use of other skin cancer procedures in the Medicare population.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was not externally funded.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was exempt from IRB approval due to the publicly available nature of this data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: There were no funding sources for this manuscript
Conflicts of Interest: The authors declare that they have no conflict of interest and no financial disclosure.
Concept and design: Puri, Mangold
Acquisition, analysis, or interpretation of data: Puri.
Drafting of the manuscript: Puri.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Puri.
Administrative, technical, or material support: Mangold.
Supervision: Mangold.
Data Availability
All data is available upon request.
